netFormulary NHS
NHS NEL
Demonstration Formulary
 Search
 Formulary Chapter 3: Respiratory system - Full Section
 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
03.01 Bronchodilators (0,4)
spacespace Asthma (0,1)
spacespace Chronic obstructive pulmonary disease (0,0)
spacespace Croup (0,0)
03.01.01 Adrenoceptor agonists (0,0)
03.01.01.01 Selective Beta2 agonists (6,7)
spacespace Short-acting beta2 agonists (0,0)
spacespace Long-acting beta2 agonists (0,1)
03.01.01.02 Other adrenoceptor agonists (1,1)
03.01.02 Antimuscarinic bronchodilators (4,3)
spacespace Short Acting Anti-muscarinic Bronchodilators (0,0)
spacespace Long Acting Anti-muscarinic Bronchodilators (0,0)
03.01.03 Theophylline (2,0)
03.01.04 Compound bronchodilator preparations (4,3)
03.01.05 Peak flow meters, inhaler devices and nebulisers (0,0)
spacespace Peak flow meters (2,2)
spacespace Drug delivery devices (2,1)
spacespace Nebulisers (0,0)
spacespace Nebuliser Diluent (1,0)
03.02 Corticosteroids (19,19)
03.02.01 Inhaled Corticosteroids (0,0)
03.02.02 Combination products (ICS+LABA) for asthma (0,0)
spacespace Low dose (0,0)
spacespace Moderate dose (0,0)
spacespace High dose (0,0)
03.02.03 Combination products (ICS+LABA) for COPD (0,0)
spacespace Triple Therapy products for COPD (6,0)
03.03 Cromoglicate, related therapy and leukotriene receptor antagonists (0,5)
03.03.01 Cromoglicate and related therapy (0,0)
spacespace Related therapy (0,0)
03.03.02 Leukotriene receptor antagonists (1,1)
03.03.03 Phosphodiesterase type-4 inhibitors (1,0)
03.04 Antihistamines, hyposensitisation, and allergic emergencies (7,22)
03.04.01 Antihistamines (0,0)
spacespace Non-sedating antihistamines (4,4)
spacespace Sedating antihistamines (4,0)
03.04.02 Allergen Immunotherapy (4,0)
spacespace Omalizumab (1,0)
03.04.03 Allergic emergencies (0,0)
spacespace Anaphylaxis (5,0)
spacespace Angioedema (7,0)
spacespace Intramuscular adrenaline (epinephrine) (0,0)
spacespace Intravenous adrenaline (epinephrine) (0,0)
spacespace Self-administration of adrenaline (epinephrine) (0,0)
03.05 Respiratory stimulants and pulmonary surfactants (0,0)
03.05.01 Respiratory stimulants (3,0)
03.05.02 Pulmonary surfactants (1,1)
03.06 Oxygen (1,0)
spacespace Long-term oxygen therapy (1,0)
spacespace Short burst oxygen therpary (0,0)
spacespace Ambulatory oxygen therapy (0,0)
spacespace Oxygen therapy equipment (0,0)
spacespace Arrangements for supplying oxygen (0,0)
03.07 Mucolytics (12,8)
spacespace Dornase alfa (1,0)
spacespace Hypertonic Sodium Chloride (2,2)
03.08 Aromatic inhalations (0,2)
03.09 Cough preparations (16,12)
03.09.01 Cough suppressants (0,2)
spacespace Palliative care (0,0)
03.09.02 Expectorant and demulcent cough preparations (2,0)
03.10 Systemic nasal decongestants (1,0)
03.11 Antifibrotics (3,0)
03.12 Other drugs for Interstitial lung disease (idiopathic pulmonary fibrosis) (3,0)
03.13 Nebulised antimicrobials for cystic fibrosis (14,0)
03.14 Monoclonal Antibody (5,0)
03.15 Cystic fibrosis (0,0)
netFormulary